Sector facing a key support level after 15% pullback from all-time high. Strategies Biotech stocks look for bounce amid bubble talk
This cyclical sector is the biggest loser in 2014 after several years of outperformance. Strategies Are consumer discretionary stocks the canary in the coal mine?
Dividend Growth portfolio manager Charles Sizemore on bank stress tests and dividends. Strategies Bank stocks may beckon dividend investors after stress tests
